Autors:

CiteWeb id: 20120000087

CiteWeb score: 2949

DOI: 10.1093/eurheartj/ehs253

Atrial fibrillation; European Society of Cardiology; Guidelines; Anticoagulation; Novel oral anticoagulants; Left atrial appendage occlusion; Rate control; Cardioversion; Rhythm control; Antiarrhythmic drugs; Upstream therapy; Pulmonary vein isolation; Left atrial ablation; Focused update; RANDOMIZED CONTROLLED-TRIAL; HEART RHYTHM ASSOCIATION; NET CLINICAL BENEFIT; RE-LY TRIAL; STROKE RISK STRATIFICATION; ACUTE CORONARY SYNDROME; RADIOFREQUENCY CATHETER ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; ORAL ANTICOAGULANT DRUGS; NORMALIZED RATIO CONTROL

Links: